A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Vectors and Compositions for Treating Hemoglobinopathies
Patent Title: Vectors and Compositions for Treating HemoglobinopathiesFiling Date: November 17, 2025Status: Patent application published / pendingAssignee: bluebird bio, Inc.Patent Category: Gene‑therapy vectors and therapeutic compositions What This Patent Covers Although the full patent specification…
-
Prime editing-installed suppressor tRNAs for disease-agnostic genome editing
Published in Nature (Nov 19, 2025) — a pioneering paper by Sarah E. Pierce, Steven Erwood, Keyede Oye, Meirui An, Nicholas Krasnow, Emily Zhang, Aditya Raguram, David R. Liu, and colleagues. This study introduced a…
-
Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences
Assignee / Owner: ToolGen, Inc. (South Korea–based genome editing technology company) Patent Number: 12,473,559 Filed: (continuation framework dating back to earlier applications; priority filings from 2020/2023) Patent Issued: November 18, 2025 Title: Cas9/RNA Complexes for…
